Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 4
2019 8
2020 6
2021 5
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Verinurad/Febuxostat and Nephrotoxicity.
Fernandez-Prado R, Ortiz A. Fernandez-Prado R, et al. Am J Kidney Dis. 2021 Sep;78(3):468. doi: 10.1053/j.ajkd.2021.03.029. Epub 2021 Jun 11. Am J Kidney Dis. 2021. PMID: 34126127 No abstract available.
Phosphate, Microbiota and CKD.
Favero C, Carriazo S, Cuarental L, Fernandez-Prado R, Gomá-Garcés E, Perez-Gomez MV, Ortiz A, Fernandez-Fernandez B, Sanchez-Niño MD. Favero C, et al. Among authors: fernandez prado r. Nutrients. 2021 Apr 13;13(4):1273. doi: 10.3390/nu13041273. Nutrients. 2021. PMID: 33924419 Free PMC article. Review.
Potential Dangers of Serum Urate-Lowering Therapy.
Perez-Gomez MV, Bartsch LA, Castillo-Rodriguez E, Fernandez-Prado R, Kanbay M, Ortiz A. Perez-Gomez MV, et al. Among authors: fernandez prado r. Am J Med. 2019 Apr;132(4):457-467. doi: 10.1016/j.amjmed.2018.12.010. Epub 2019 Jan 3. Am J Med. 2019. PMID: 30611833 Review.
Who killed Bruce Lee? The hyponatraemia hypothesis.
Villalvazo P, Fernandez-Prado R, Niño MDS, Carriazo S, Fernández-Fernández B, Ortiz A, Perez-Gomez MV. Villalvazo P, et al. Among authors: fernandez prado r. Clin Kidney J. 2022 Mar 10;15(12):2169-2176. doi: 10.1093/ckj/sfac071. eCollection 2022 Dec. Clin Kidney J. 2022. PMID: 36381374 Free PMC article.
Slo-Mo anti-neutrophil cytoplasmic antibody-associated renal vasculitis.
Avello A, Fernandez-Prado R, Santos-Sanchez-Rey B, Rojas-Rivera J, Ortiz A. Avello A, et al. Among authors: fernandez prado r. Clin Kidney J. 2020 Nov 9;14(1):18-22. doi: 10.1093/ckj/sfaa181. eCollection 2021 Jan. Clin Kidney J. 2020. PMID: 33564403 Free PMC article.
Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences.
Fernandez-Prado R, Villalvazo P, Avello A, Gonzalez-de-Rivera M, Aguirre M, Carrasco-Muñoz CG, Fernandez-Fernandez B, Martin-Cleary C, Carriazo S, Sanchez-Niño MD, Perez-Gomez MV, Ortiz A. Fernandez-Prado R, et al. Biomed Pharmacother. 2023 Feb;158:114197. doi: 10.1016/j.biopha.2022.114197. Epub 2023 Jan 4. Biomed Pharmacother. 2023. PMID: 36916426 Free article. Review.
31 results